Respiratorius
1.35 SEK
+3.85 %
Less than 1K followers
RESP
Spotlight Stock Market
Biotechnology & Pharmaceuticals
Health Care
Overview
Financials & Estimates
Ownership
Dividend
Investor consensus
Valuation
Income statement
Quarter data
Income statement
Financial statements, revenue, EBIT, valuation metrics, and quarterly estimates for Respiratorius
| 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | |
|---|---|---|---|---|---|---|---|
| Revenue | |||||||
| growth-% | |||||||
| EBITDA | -3.1 | -4.5 | -6.5 | -4.4 | -4.5 | -4.1 | -3.5 |
| EBIT | -5.1 | -7.1 | -9.6 | -6.0 | -7.8 | -7.5 | -7.0 |
| Profit before taxes | -5.1 | -7.5 | -9.6 | -6.3 | -7.8 | -7.6 | -7.0 |
| Net income | -5.1 | -7.5 | -9.6 | -6.3 | -7.8 | -7.6 | -7.0 |
| EPS | -2.77 | -3.47 | -3.94 | -1.83 | -2.75 | -1.89 | -1.17 |
| Dividend | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Dividend ratio | -0.0 % | -0.0 % | -0.0 % | -0.0 % | -0.0 % | -0.0 % | -0.0 % |
Profitability and return on capital
| 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | |
|---|---|---|---|---|---|---|---|
| EBITDA-% | |||||||
| EBIT-% | |||||||
| ROE | -31.5 % | -25.5 % | -17.0 % | -18.3 % | -29.5 % | -25.1 % | -22.7 % |
| ROI | -28.4 % | -24.2 % | -15.5 % | -17.6 % | -28.1 % | -24.4 % | -21.8 % |